Posted on January 23rd, 20201/23/20
EVERSANA to commercialize and distribute Gimoti in the U.S. SOLANA BEACH, CA, and CHICAGO, IL. January 23, 2020 – Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, and EVERSANA™, an independent provider of global commercial services to the life science industry, today announced a collaboration to utilize […]
Posted on January 9th, 20201/9/20
CHICAGO – January 9, 2020 – EVERSANA™, the leading independent provider of commercial services to the life science industry, and Noom, the world’s leading behavior change company, today announced a collaboration to increase medication adherence and improve health outcomes for the millions of patients suffering from chronic conditions and rare diseases worldwide. The partnership combines […]
Posted on January 7th, 20201/7/20
CHICAGO – January 7, 2020 – EVERSANA™, the leading independent provider of commercial services to the life science industry, today unveiled EVERSANA ENGAGE, the full-solution healthcare marketing agency uniquely designed to help pharmaceutical and biotechnology companies cohesively reach patients, providers and payers to enhance the patient experience and improve outcomes. EVERSANA ENGAGE combines EVERSANA’s market […]
Posted on October 30th, 201910/30/19
CHICAGO – October 30, 2019 – EVERSANA™, the leading independent provider of commercial services to the life science industry, today announced an agreement to acquire Canada-based Cornerstone Research Group, Inc. Headquartered in Burlington, Ontario with an additional location in Sydney, Nova Scotia, Cornerstone Research Group is the leader in Health Economics and Outcomes Research (HEOR) […]
Posted on October 28th, 201910/28/19
CHICAGO – October 28, 2019 – EVERSANA™, the leading independent provider of commercial services to the life science industry, has been certified as a Great Place to Work® by the global authority in workplace culture. EVERSANA ranked in the top 15 percent of more than 6,000 organizations worldwide who have submitted for the coveted certification. […]
Posted on October 24th, 201910/24/19
Chicago– October 24, 2019 – EVERSANATM, the leading independent provider of global commercial services to the life science industry, today appointed oncology veteran Suzanne Greenwood, RN, BSN, to Senior Vice President, Commercial Solutions. Greenwood joins EVERSANA after more than three decades at leading clinical and pharmaceutical manufacturers, distributors, and technology companies, including Bristol-Myers Squibb, McKesson, […]
Posted on October 10th, 201910/10/19
CHICAGO – October 10, 2019 – EVERSANA,™ the leading independent provider of global, commercial services to the life science industry, today announced the expansion of its channel management and 3PL (third party logistics) operation with the addition of a new 260,000 square foot Verified-Accredited Wholesale Distributor (VAWD) certified distribution center in Memphis, Tennessee. The new […]
Posted on September 10th, 20199/10/19
PALO ALTO, Calif. And CHICAGO – September 10, 2019 – Cognoa, a company at the forefront of pediatric behavioral health, and EVERSANA™, the leading independent provider of global commercial services to the life science industry, today announced a partnership to advance the industry standard by which digital medicines will be ordered, dispensed, and covered by […]
Posted on August 6th, 20198/6/19
CHICAGO – August 6, 2019 – EVERSANA™, the leading independent provider of global commercial services to the life science industry, today announced the rapid expansion of its Asia Pacific business with the addition of two new offices in Singapore and Mumbai. The announcement comes as the company appoints a regional leadership team which will be […]
Posted on July 11th, 20197/11/19
IRVINE, California, July 11, 2019 – Cryoport, Inc. (NASDAQ: CYRX) (NASDAQ: CYRXW) and EVERSANA™ have announced a strategic alliance to further create a fully integrated regenerative medicine supply chain solution. The alliance will be designed to leverage EVERSANA’s position as the leading provider of commercial services addressing access, affordability and adherence challenges for cell and […]
